The study will assess the safety and feasibility of a new medical device, MIPP-Kit, for the prevention of complications during diagnostic, CT guided ,percutaneous lung needle biopsy.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
40
Patients will undergo the usual biopsy procedure with a fine needle inserted through a larger guide needle, under CT guidance; at the end of the biopsy, the MIPP-Kit will be introduced through the same guide needle. The guide needle and the MIPP Kit will be retracted together slowly, whilst injecting BioGlue in appropriate amounts along the whole track, from the lesion to the skin.
Istituto Tumori Bari Giovanni Paolo II
Bari, Italy
Fondazione Policlinico Universitario A. Gemelli
Roma, Italy
Azienda Ospedaliera Universitaria Integrata Verona
Verona, Italy
Rate of complications associated with percutaneous lung biopsy
incidence of clinical complications commonly associated with lung biopsy (pneumothorax and haemorrhage)
Time frame: 48 hours after procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.